Home › Employers › Archbold Medical Group, Inc.
Archbold Medical Group, Inc.: H-1B salaries and sponsorship
Archbold Medical Group, Inc. filed 5 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 5. Median offered salary: $430,000.
Does Archbold Medical Group, Inc. sponsor H-1B visas?
Archbold Medical Group, Inc. filed 5 labor condition applications in fiscal years 2023–2026, the latest submitted on Jan 27, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Pulmonary/Critical Care Physician | 2 | $430,000 |
| Neuro Hospitalist | 1 | $340,000 |
| Infectious Disease Physician | 1 | $250,000 |
| Gastroenterologist | 1 | $750,000 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 1 | $430,000 |
| FY2024 | 1 | $340,000 |
| FY2025 | 2 | $500,000 |
| FY2026 | 1 | $430,000 |
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Pulmonary/Critical Care Physician | $430,000 | Thomasville, GA | Jan 27, 2026 | Jul 29, 2026 | Certified |
| Gastroenterologist | $750,000 | Thomasville, GA | Sep 16, 2025 | Oct 16, 2025 | Certified |
| Infectious Disease Physician | $250,000 | Thomasville, GA | Dec 9, 2024 | Dec 29, 2024 | Certified |
| Neuro Hospitalist | $340,000 | Thomasville, GA | Apr 30, 2024 | Aug 1, 2024 | Certified |
| Pulmonary/Critical Care Physician | $430,000 | Thomasville, GA | Jan 27, 2023 | Jul 29, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).